Appetite-Suppressant Supplements Ranked by Evidence: Glucomannan to 5-HTP

Prescription appetite suppression works well enough in 2026 that the supplement version of the same promise has to shout louder to be heard. Walk the aisle and every bottle claims to curb hunger: fiber blends, plant extracts, amino acids, chromium-and-caffeine stacks. The claims are uniform. The evidence behind them is not — it ranges from “modest but real, with a regulator’s approval on record” to “one small trial and a lot of hope.”

This is an evidence ranking, tier by tier, with the honest ceiling for each. Nothing on this list approaches prescription effect sizes, and none is FDA-approved for weight loss — US supplements are regulated as foods under DSHEA, meaning no pre-market efficacy review is required. Where an ingredient carries genuine interaction risk, it is flagged.

Tier 1: modest evidence, plausible mechanism

Glucomannan. The strongest candidate in the aisle, and it is still not impressive. Glucomannan is a highly viscous soluble fiber from konjac root that absorbs water, expands in the stomach and slows gastric emptying. Notably, the European Food Safety Authority authorized a health claim that glucomannan “contributes to the reduction of body weight in the context of an energy-restricted diet” at 3 g/day in three doses with water — one of very few weight-related claims EFSA has ever approved. Human trials are mixed: some show 1–2 kg advantages over 8–12 weeks; a well-conducted trial published in 2013 found no significant difference from placebo. Safety note that matters: glucomannan tablets have caused esophageal obstruction when taken with too little water, so capsules or powder with a full glass are the standard advice.

Protein itself — not a supplement gimmick, but the most reliable appetite intervention available over the counter. Higher-protein diets consistently increase satiety and reduce spontaneous intake in controlled feeding studies, and a whey or casein shake is cheaper per effective dose than most branded “appetite formulas.”

Tier 2: weak or mixed evidence

Psyllium. Another viscous fiber, better established for cholesterol and bowel regularity than for appetite. Trials show small satiety effects; weight effects are inconsistent and generally under 1–2 kg. Cheap, safe, useful for fiber gap-closing — the CDC and Dietary Guidelines put adequate fiber near 25 g/day for women and 38 g/day for men, and most Americans fall far short.

Caffeine. Genuine, well-documented short-term effects: modest appetite suppression, a small thermogenic bump (roughly 3–5% in metabolic-rate studies), and improved exercise performance. The catch is tolerance — the appetite effect fades within weeks of regular use. FDA guidance considers up to 400 mg/day generally safe for healthy adults; higher intakes bring insomnia, anxiety and cardiovascular effects.

Green tea extract (EGCG). Meta-analyses cluster around a 1 kg or smaller average difference, likely driven mostly by the caffeine content. Important safety flag: concentrated green tea extracts have been linked to liver injury case reports documented in NIH’s LiverTox, prompting EFSA scrutiny of high-dose EGCG. Drinking green tea carries none of this concern.

5-HTP. A serotonin precursor with an appealing mechanism — serotonin signaling is genuinely involved in satiety, and older prescription appetite drugs worked on that pathway. The human evidence is thin: a handful of small trials from the 1990s, mostly under 30 participants, reporting reduced intake. There has been little quality replication since. Critically, 5-HTP carries real interaction risk: combining it with SSRIs, SNRIs, MAOIs, triptans or tramadol raises the risk of serotonin syndrome. This is a supplement that requires a clinician conversation, not a cart click.

Tier 3: little or no credible support

Garcinia cambogia (HCA). A 1998 randomized trial in JAMA with 135 participants found no significant weight-loss difference versus placebo — an unusually clean negative result for a supplement — and later reviews concluded any effect is small and uncertain. It also appears in liver-injury case reports.

Hoodia gordonii. Once heavily hyped as a San-tradition appetite suppressant; a company-run clinical trial reportedly showed no meaningful benefit alongside tolerability problems, and development was abandoned. Products sold today frequently do not contain authentic material.

Saffron extract, gymnema, forskolin, raspberry ketones. Each has a small trial or a mechanistic story; none has replicated, independent evidence of clinically meaningful appetite or weight effects.

The ranking at a glance

Ingredient	Evidence tier	Honest expected effect	Key caution
Protein (whey/casein/food)	Best supported	Reliable satiety increase; supports lean mass	None for most; count it in calories
Glucomannan	Tier 1 (EFSA-authorized claim)	~1–2 kg over 8–12 weeks at 3 g/day, if any	Choking/obstruction risk without adequate water
Psyllium	Tier 2	Small satiety benefit; weight effect inconsistent	Start low; increase fluids
Caffeine	Tier 2	Short-term appetite and energy-expenditure effects	Tolerance develops; ≤400 mg/day for healthy adults
Green tea extract	Tier 2	≤1 kg average in pooled trials	Liver-injury case reports at concentrated doses
5-HTP	Tier 2 (thin)	Small intake reduction in old, small trials	Serotonin syndrome risk with antidepressants and triptans
Garcinia cambogia	Tier 3	No reliable effect (JAMA 1998 null trial)	Liver case reports
Hoodia, forskolin, raspberry ketones	Tier 3	No credible human evidence	Frequent product-authenticity problems

How to run a supplement trial on yourself

1. Fix the free variables first. Protein at roughly 1.2–1.6 g/kg/day, fiber toward 25–38 g/day, and 7+ hours of sleep suppress appetite more reliably than anything sold in a bottle — sleep restriction alone raises ghrelin and adds hundreds of calories of intake drive in lab studies.
2. One ingredient at a time. Proprietary blends make it impossible to know what did or didn’t work — and hide doses.
3. Use the studied dose. Glucomannan’s evidence exists at 3 g/day in divided doses with water, not at the 500 mg sprinkled into a multi-ingredient formula.
4. Choose third-party-tested products (USP, NSF, Informed Choice) — content verification is the manufacturer’s responsibility under US law.
5. Set a 12-week decision point and measure waist plus weekly average weight, then stop if nothing has moved.
6. Check interactions before you start, particularly with antidepressants (5-HTP), stimulants and blood-pressure medication (caffeine, green tea extract), and any diabetes medication.
7. Tell your prescriber if you are on GLP-1 therapy: fiber-based products can compound the fullness and GI effects of slowed gastric emptying.

The verdict

Ranked honestly, the appetite-suppressant aisle has one ingredient with a regulator-approved claim and a ceiling of a kilogram or two (glucomannan), a couple with small short-term effects that fade or carry liver and interaction risks (caffeine, green tea extract, 5-HTP), and a long tail of ingredients that have failed or never been properly tested. The best-performing product in the category is a protein powder, which nobody markets as an appetite suppressant. Spend accordingly: fix protein, fiber and sleep, treat any supplement as a 12-week experiment with a stop date, and reserve the serious expectations for interventions — behavioral programs and, where medically appropriate, prescription therapy — whose trials are measured in double-digit percentages rather than single kilograms.

Do appetite suppressants work while on a GLP-1?

There is no evidence they add benefit, and fiber-based products may worsen nausea and fullness when gastric emptying is already slowed. Ask your prescriber before adding anything.

Is 5-HTP safe with antidepressants?

This combination is specifically risky — both raise serotonin activity, and serotonin syndrome is a medical emergency. Do not combine them without a clinician’s explicit direction.

Why do “clinically proven” claims appear on Tier 3 products?

Because US law lets manufacturers make structure/function claims with a disclaimer, without FDA review of efficacy. “Clinically studied” can legally describe one small, sponsor-funded trial that found nothing meaningful.

What about prescription appetite medications?

They exist, work far better, and require medical supervision — that is precisely the trade. Effect sizes in the GLP-1 trials (about 15% of body weight with semaglutide 2.4 mg in STEP 1) sit an order of magnitude above anything in this article.